21 Grants
This is a chronological listing of grants held by this department, with the most recent listed first. New grants appear in this list quarterly and contribute to the department's Research Profile. The source of grants for this application comes directly from your institution.
-
1.
Sendurai Mani
Targeting aberrant FOXC2 functions in EMT, cancer stem cells and metastasis
1/1/2012 - 12/31/2015
Sponsor: American Cancer Society, National
-
2.
Sendurai Mani
Pleiotropic functions of FOXC2 in EMT, stem cells and breast cancer progression
3/16/2011 - 2/29/2016
Sponsor: National Cancer Institute - DHHS - NIH
-
3.
Macus Kuo
Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy
9/23/2010 - 4/30/2015
Sponsor: National Cancer Institute - DHHS - NIH
-
4.
Ignacio Wistuba
Molecular Profiles for Lung Cancer Pathogenesis and Detection in U.S. Veterans.
9/20/2010 - 10/19/2014
Sponsor: US Department of Defense
-
5.
Macus Kuo
Mechanism of Resistance to Arginine Deiminase Therapy in Advance Melanoma
9/17/2010 - 7/31/2014
Sponsor: National Cancer Institute - DHHS - NIH
-
6.
Sue-Hwa Lin
Cadherin-11 as a Target for Bone Metastasis Prevention
3/1/2010 - 3/31/2013
Sponsor: US Department of Defense
-
7.
-
8.
Ralph Arlinghaus
Interfering Breast Cancer Metastasis by Blocking NGAL Function
9/1/2008 - 9/30/2011
Sponsor: US Department of Defense
-
9.
Sue-Hwa Lin
Bone Metastasis Factor-1 in Prostate Cancer/Bone Interaction
7/1/2005 - 4/30/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
10.
Peng Huang
Mitochondrial Defects and Cancer Therapeutics
7/7/2004 - 4/30/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
11.
Peng Huang
Antitumor Activity & Mechanism of OSW-1 in Pancreatic Cancer
4/8/2004 - 3/31/2006
Sponsor: National Cancer Institute - DHHS - NIH
-
12.
Macus Kuo
Genomic Instability and Evolution of Drug Resistance
4/1/2004 - 2/28/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
13.
Kun-Sang Chang
Regulation of Gene Expression by PML
9/30/2003 - 6/30/2010
Sponsor: National Cancer Institute - DHHS - NIH
-
14.
Peng Huang
Novel Roles of p53 & ROS in Therapy of Refractory CLL
5/1/2003 - 5/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
15.
Ralph Arlinghaus
Jak2 Involvement in Bcr-Abl oncogenic transformation
5/1/2003 - 4/30/2008
Sponsor: National Cancer Institute - DHHS - NIH
-
16.
Macus Kuo
Targeted Prodrug Therapy of Liver Cancers
9/1/2002 - 8/31/2008
Sponsor: National Cancer Institute - DHHS - NIH
-
17.
Subrata Sen
Aurora-A/BTAK/STK15 Oncoprotein in Mitotic Spindle Assembly and Checkpoint Response
12/1/2000 - 7/31/2013
Sponsor: National Cancer Institute - DHHS - NIH
-
18.
Peng Huang
Superoxide, ROS, and novel targets for cancer therapy
4/1/2000 - 7/31/2012
Sponsor: National Cancer Institute - DHHS - NIH
-
19.
Macus Kuo
Redox Regulation of Multidrug Resistance Gene Expression
8/1/1999 - 4/30/2011
Sponsor: National Cancer Institute - DHHS - NIH
-
20.
Macus Kuo
Regulation of MDR Gene Expression in Liver Cancers
5/9/1997 - 8/31/2007
Sponsor: National Cancer Institute - DHHS - NIH
-
21.
Kun-Sang Chang
A Role for PML in Genome Stability and DNA Damage Response
9/1/1992 - 2/28/2013
Sponsor: National Cancer Institute - DHHS - NIH
